Homenewsabout usContact UsWebsite
Welcome to the
Cipla Press Office
Cipla is a global pharmaceutical company whose goal is ensuring no patient shall be denied access to high quality & affordable medicine and support.
Follow us:
The Cipla Foundation contributes to the vaccine rollout through partnership
Collaboration is the key to achieving population immunity
 2 Aug 2021 Read more

During these unprecedented times, our healthcare workers have shown that superheroes don't always wear capes. 7 Jun 2021 Read more

Bronki Boosters: Turning children with asthma into superheroes
According to the 2018 Global Asthma Report, asthma is the most common chronic illness in South African children and has shown an increasing prevalence in both urban and rural areas. Second-hand smoke exposure and living in highly populated areas can exacerbate asthma in young children. 8 Apr 2021 Read more

Access and affordability: South African launch of critical medications drives equitable access
In putting healthcare in South Africa under the microscope, Covid-19 has exposed many weaknesses inherent in the country's fractured socio-economic environment. Yet, even before the pandemic reached our shores, equitable access to healthcare posed a significant obstacle for South Africa - a side effect of a tumultuous past. 2 Feb 2021 Read more

Cipla launches affordable tetanus vaccine to prevent tetanus deaths
While the world remains focused on containing the spread of Covid-19, this should not avert our attention away from the ongoing battle to eradicate the many other diseases that can affect the quality of life for millions of South Africans. 8 Dec 2020 Read more

Landmark oncology drug registration
In what is groundbreaking news for cancer sufferers diagnosed with blood cancers such as multiple myeloma (MM) or myelodysplastic syndromes, Cipla recently received regulatory approval for lenalidomide - a lifesaving immunomodulatory drug that activates and increases the number of immune system cells that identify and attack cancer cells - to bring this medication into the South African market at affordable prices. This will help to ensure that more cancer patients have access to this treatment, in line with Cipla's ethos of 'caring for life'. 7 Dec 2020 Read more

Alvotech and Cipla partner to ensure access to biosimilars in South Africa
Biopharmaceutical company Alvotech and Cipla Medpro, a wholly-owned subsidiary of the leading global pharmaceutical company Cipla Limited (BSE: 500087; NSE: CIPLA EQ; hereafter referred to as "Cipla"), have entered into an exclusive partnership to bring key biosimilars to patients in emerging markets such as South Africa. The biosimilar portfolio will include five biosimilar medicines - two for oncology and three for treating auto-immune diseases. 5 Nov 2020 Read more

IDA awards top industry honour to Greater Tygerberg Partnership
IDA presents awards recognising innovative achievement in urban place management 12 Oct 2020 Read more

Covid-19 drug, Remdesivir, arrives in SA
Remdesivir, a medicine which could make a difference in the management of severe Covid-19 disease, is available in South Africa now. Cipla obtained authorisation from the South African Health Products Regulatory Authority ("SAHPRA") to import this medicine under Section 21 of the Medicines and Related Substances Act. Cipla is working closely with SAHPRA and healthcare facilities to ensure access to remdesivir. 4 Aug 2020 Read more

Cipla gets ready to bring Covid-19 treatment to SA
Cipla through a landmark agreement with Gilead Sciences Inc., was granted a license to manufacture and distribute the antiviral medicine, remdesivir, in 127 countries, including South Africa. As many of these countries are low-income countries and emerging markets that face obstacles in accessing healthcare, Cipla will expand supply to several sub-Saharan African countries. 6 Jul 2020 Read more

Cipla calls on South Africans to visibly show their care for carers during Covid-19
Support #Socks4Docs initiative to shine a light on healthcare workers' mental health. 1 Jun 2020 Read more

Cipla Foundation deploys Strandfontein modular medical facility
In response to an urgent call from the City of Cape Town for assistance with temporary medical infrastructure at the Strandfontein Sports Ground - a site that is housing the bulk of the city's homeless individuals during the Covid-19 lockdown - the Cipla Foundation was able to deploy a fully functioning medical facility within just two days. 6 May 2020 Read more

Cipla and partners launch 'The Lockline' because laughter can be the best medicine
Many South Africans were hoping to wake up on 1 May 2020 to the end of the nationwide lockdown. Instead, they may decide to do a little morning exercise before 9am and then catch a new short-form comedy show called The Lockline, a collaboration between Cipla, Both Worlds Pictures and some of South Africa's top comedians. 4 May 2020 Read more

In light of social distancing, patients are seeking alternative solutions to interacting with their doctors. 29 Apr 2020 Read more

Sha'p Left to help scale up Covid-19 testing
In order to help curb the spread of Covid-19 in South Africa, President Cyril Ramaphosa and Health Minister, Dr Zweli Mkhize recently announced the implementation of a comprehensive screening and testing programme. 20 Apr 2020 Read more

Laughter is the best medicine with Cipla
As a nation, South Africans have a talent for laughing through the good times and using humour to help us get through the uncertain times too. 14 Apr 2020 Read more

Another SA First - Cipla's combination TB-Preventative therapy in one tablet
With South Africa having one of the highest rates of tuberculosis (TB) worldwide, coupled with equally high statistics of people living with HIV (PLHIV), two of the biggest issues in reducing both these numbers are access and adherence to medication. 7 Apr 2020 Read more

Cipla partners with Cricket SA for the Covid-19 awareness #NoHands challenge
When we watch the Protea cricket teams the last thing we want to see is them not using their hands - that was until Covid-19 came along. For the next 21 days, people can see their cricketing heroes showing off their 'no hands' catching techniques while throwing out the challenge to teammates and other sports stars to do the same. 2 Apr 2020 Read more

As South Africa is currently in a three-week nationwide lockdown to combat the spread of the novel coronavirus (Covid-19), many people are experiencing heightened feelings of uncertainty, unrest and loneliness. 1 Apr 2020 Read more

#Covid-19 - A message from Cipla
The world has changed significantly with the outbreak of the coronavirus (Covid-19), and the pandemic is having significant repercussions globally. 27 Mar 2020 Read more

Cipla's Mirren facility approved by Sahpra to produce vital medicine
At a time when South Africa desperately needs some good news, Cipla's upgraded Mirren facility will not only be able to meet the high demand for critical medical needs but also help grow the beleaguered economy. 24 Mar 2020 Read more

Your work helps to make a difference, save a life 17 Mar 2020 Read more

Thanks to the efforts of the South African Health Products Regulatory Authority (SAHPRA) with their Backlog clearance project which launched in August 2019, considerable progress has been made in terms of the number of applications to register new medication. 12 Mar 2020 Read more

Prioritising testing and treatment in 2020
The Cipla Foundation, through its Sha'p Left initiative, provides high-quality, customised chronic medicine pick-up point facilities (PUPs) around the country and recently landed its 20th PUP. 11 Mar 2020 Read more

Cipla working to end neglect of paediatric HIV
Almost all parents can attest to the struggle experienced at mealtimes - think aeroplane noises and bribery - to get an infant or toddler to just eat their veggies. Now, imagine trying to administer a metallic tasting medicine, which must be squirted into the child's mouth with a syringe twice daily or trying to get them to swallow a tablet whole. This is the struggle that mothers of children living with HIV (CLHIV) have had to endure daily with the paediatric antiretroviral (ARVs) formulations available. 9 Mar 2020 Read more

Cipla SA signs agreement for anti-psychotic drug
As part of its quest to provide access to life-saving medication and making a difference in the lives of patients, Cipla Medpro, wholly-owned subsidiary of Cipla Limited, India (Cipla) and South Africa's third-largest pharmaceutical company in the private sector, recently concluded an exclusive agreement securing originator and authorised generic brands of an atypical antipsychotic drug, Quetiapine. 13 Feb 2020 Read more

The future of HIV treatment is in empowering patients
Cipla, South Africa's third-largest pharmaceutical manufacturer, hosted an HIV/AIDS workshop in Sandton on Wednesday, ahead of World AIDS Day on 1 December 2019. 6 Dec 2019 Read more

The Medicines Patent Pool announces new licensee for HIV paediatric treatment
On World AIDS Day, the Medicines Patent Pool (MPP) announced a sublicence agreement with Indian manufacturing partner Cipla for the development, manufacture and supply of HIV treatment lopinavir (LPV) and ritonavir (RTV or r) individually or in combination, for paediatric use. 6 Dec 2019 Read more

The Cipla Foundation, in collaboration with the Greater Tygerberg Partnership has launched a new community-based healthcare hub at the Bellville taxi rank that will provide primary healthcare services, eyecare and a chronic medicine pick-up point to the scores of commuters that pass through this area on a daily basis. 3 Dec 2019 Read more

Cipla Foundation brings chronic medicine closer to Tembisans
Cipla Foundation has secured funding from the US Government from the US president's Emergency Plan for Aids Relief (PEPFAR), through the United States Agency for International Development (USAID) on 4 November. 25 Nov 2019 Read more

SA men, don't Faf this up
Be ballsy enough to check your crown jewels 22 Nov 2019 Read more

Cipla launches campaign to create awareness around dementia, Alzheimer's disease
As a result of advances in medication, globally, people are living longer. While longer life expectancy is a positive trend, the focus on cognitive wellbeing becomes incredibly important, as dementia becomes increasingly probable in an ageing population. 21 Nov 2019 Read more

Cipla chairman Dr. Yusuf Hamied elected Royal Society Honorary Fellow
Cipla Medpro is proud to announce that Dr. Yusuf Hamied, Cipla's Chairman, has been elected an Honorary Fellow of the Royal Society, U.K. for his service to the cause of science. 2 Aug 2019 Read more

Community clinic opens in Pretoria East
The Cipla Foundation, in partnership with Intercare, the Kungwini Welfare Organisation, and the Dutch Reformed Church of Tygerpoort, have announced the launch of the Tshwenyega Community Clinic in Tshwane which will provide primary healthcare services to the people of Kungwini and the Pretoria East region. 2 Aug 2019 Read more

Raising awareness one sock at a time
We tend to think of doctors as the professionals we turn to when we are suffering, but we often forget that they are still people who also need help from time to time. The same applies to medical students, who study under immense strain as doctors-to-be. 25 Jul 2019 Read more

Participate in the Miles for Smiles Youth Day run to make a real difference
Calling all runners, walkers and fun lovers! Join the Miles for Smiles Youth Day fun run presented by Miltons Matsemela Attorneys, on Sunday 16 June 2019 on Melkbosstrand beach at 10am and make a real difference in the lives of children born with cleft lips and palates. There are also amazing lucky draw prizes up for grabs and all participants will receive a medal. Most importantly BRING THE KIDS along. 28 May 2019 Read more

Now more patients with chronic illnesses have easy access to life-saving medication
The Cipla Foundation has announced the launch of four new Central Chronic Medicines Dispensing and Distribution (CCMDD) pick-up point facilities in Kwa-Zulu Natal. 13 May 2019 Read more

New ECD centre to uplift Gugulethu
Research shows that during the first 1,000 days of a child's life, their ability to learn, grow and thrive can be profoundly impacted by the level of care, nutrition and education they receive during this period. However, quality foundation-phase education is still one of the main challenges currently facing South Africa. 18 Apr 2019 Read more

In recognition of the importance of the critical shift to a more patient-centric, integrated and predictive healthcare environment, Cipla Medpro South Africa (Pty) Limited ("Cipla Medpro"), wholly-owned subsidiary of Cipla Limited (BSE: 500087; NSE: CIPLA EQ; hereafter referred to as "Cipla") and South Africa's third largest pharmaceutical company in the private sector, will acquire a 30% stake upon closure in the connected healthcare company, Brandmed (Pty) Limited. In February, Cipla had announced a similar partnership in India with Wellthy Therapeutics to offer a clinically-validated digital disease management platform to patients in cardio-metabolic health. 16 Apr 2019 Read more

Now more patients with chronic illnesses have easy access to life-saving medication
The Cipla Foundation has announced the launch of four new Central Chronic Medicines Dispensing and Distribution (CCMDD) pick-up point facilities in Tongaat, Hambanathi, Trenance Park and Cotton Lands in KwaZulu-Natal. This follows the successful launch of a CCMDD pick-up point in Verulam just over a year ago. 11 Apr 2019 Read more

'It's ok not to be ok' - that's the message behind new film Skemerson
Mental illness, and the stigma surrounding it, is a critical issue in South Africa. It's the central theme in 'Skemerson' ('Sun Cry Moon'), the new film directed by Phillip Rademeyer and written by Pietie Beyers, which opens nationwide on 3 May 2019. 5 Apr 2019 Read more

Don't miss an interesting educational session about the mental health challenges impacting men 28 Mar 2019 Read more

An icy lake in Finland is set to be the stage for a South African free diver's daring attempt to beat a Guinness World Record - all to raise awareness for the plight of those suffering from mental illness. 7 Mar 2019 Read more

Cipla wins portion of state ARV tender
Cipla, South Africa's third largest pharmaceutical manufacturer, announced that it has been awarded a share of the South African Government's National ARV tender for TEE and TLD. The contract is effective from 1 July 2019 and is valid for three years. 22 Feb 2019 Read more

Research suggests that the attitude towards people with mental illness became more stigmatised over the past few decades. 5 Feb 2019 Read more

World Aids day - Cipla launches new triple-combination antiretroviral drug, Reydin
Cipla has launched its new triple-combination ARV treatment for HIV in South Africa. 3 Dec 2018 Read more

World Diabetes Day 14 November - Preventing diabetes - key to a longer and better life
The prevalence of diabetes in adults is increasing worldwide, and it is predicted that by 2040, this condition will become one of the leading causes of death in South Africa. 16 Nov 2018 Read more

The road ahead for the pharma industry
In recent years, South Africa's pharmaceutical industry has increasingly shifted its focus to become more patient-centric in everything that it does. However, in the current challenging economy, building on this positive change and delivering greater results for consumers is becoming ever more challenging. Companies operating in this sector will therefore need to adapt and embrace new strategies. 24 Oct 2018 Read more

Get sweaty for a great cause
The STBB4Good Twilight Run and MTB Challenge takes place next weekend, 12 and 13 October 2018, at the Overgaauw Wine Estate in Stellenbosch. 10 Oct 2018 Read more

Improve the world one smile at a time this World Smile Day
Hike up Table Mountain for corrective cleft lip and palate surgery 1 Oct 2018 Read more

Understanding depression and related symptoms key to suicide prevention in SA
According to the World Health Organisation (WHO), South Africa has the sixth highest rate of suicide in Africa, with the data revealing that approximately 11.6 of every 100,000 people in the country completing suicide1. It is commonly accepted that the majority of suicides and suicide attempts occur among individuals who suffer from undiagnosed and untreated depression, with the WHO estimating that more than 300 million people are affected by depression worldwide2. 18 Sep 2018 Read more

Cipla's new triple-combination antiretroviral drug approved
The South African Health Products Regulatory Authority (SAHPRA) has approved Cipla's latest first-line triple-combination antiretroviral (ARV) treatment for HIV. The new combination medicine commonly referred to as TLD, is a combination of tenofovir (TDF), lamivudine (3TC) and dolutegravir (DTG). 12 Sep 2018 Read more

Cipla South Africa grows national footprint with Mirren acquisition
Cipla Medpro South Africa (Pty) Limited ("Cipla Medpro"), wholly owned subsidiary of Cipla Limited, India ("Cipla"), and South Africa's fourth-largest pharmaceutical company in the private sector, has announced its plans to acquire a 100% stake in Mirren (Pty) Limited ("Mirren"). Mirren is a South African over-the-counter (OTC) pharmaceutical manufacturer and distributor, which has been in operation for 35 years. The transaction is subject to the approval by the Competition Commission of South Africa. 8 Aug 2018 Read more

South Africa's first biosimilar oncology drug authorised for use
Cipla, South Africa's third-largest pharmaceutical manufacturer, in collaboration with Teva Pharmaceutical Industries Ltd, has announced the launch of the country's first biosimilar for the oncology and haematology markets. 3 Aug 2018 Read more

The Fourth Industrial Revolution is having a profound effect on the pharmaceutical industry, as new technology is assisting with earlier diagnoses, enhanced manufacturing capabilities, and improved treatment plans by using data to better understand patients' needs, said Cipla South Africa CEO, Paul Miller, at the BRICS 2018 summit, held in Johannesburg. 31 Jul 2018 Read more

Pioneering affordable HIV/AIDS treatment in Africa Cipla's continued goal
There are still several significant challenges that need to be addressed to ensure that people living with HIV (PLHIV) have better access to affordable, quality treatment. According to Dr Nobulumko Xhantini, Medical Affairs Executive at Cipla South Africa, these challenges include finding innovative means to reduce the pill burden associated with treating HIV and preventing co-infections such as tuberculosis (TB); as well as disseminating information to the caregivers, women and treating healthcare practitioners. 30 Jul 2018 Read more

Cipla Foundation's initiative, Sha'p Left, won the certificate of excellence award in the healthcare category at the recent annual 2018 Vision 2030 awards ceremony. 12 Jul 2018 Read more

SA consumers need to be informed to avoid risk of opioid addiction
South Africans need to better understand the potential risks associated with using medication to combat pain, as even the use of certain pain medications, could lead to an individual needing professional help for addiction to opioids. 5 Jul 2018 Read more

David Grier already halfway and might be first person to run The Great Wall of China in both directions
Extreme explorer, Cipla Foundation trustee and ambassador David Grier and fellow extreme athlete Andrew Stuart have passed the halfway mark of their gruelling 70-day, 4,200-kilometre journey across the Great Wall of China. 21 May 2018 Read more

South Africans urged to have their blood pressure tested regularly
Globally, it is estimated that approximately 7.5 million people die annually from complications due to high blood pressure (also known as hypertension). The Heart and Stroke Foundation of South Africa estimates that more than one in every three South African adults is currently living with hypertension, a condition that is responsible for as much as 50% of reported strokes and 40% of heart attacks. 21 May 2018 Read more

Educating children about asthma is the best way to manage symptoms
South Africa has the highest asthma death rate in the world - according to the World Health Organisation's (WHO) Detailed Mortality Database - and globally 334 million people are estimated to suffer from asthma.1 2 May 2018 Read more

World Primary Immunodeficiency Week 22-29 April 2018
'My future starts with early testing and diagnosis of Primary Immunodeficiency' 30 Apr 2018 Read more

Cipla Foundation's David Grier takes on the Great Wall of China - again
Extreme explorer, Cipla Foundation trustee and ambassador, David Grier, embarked on 28 March 2018 to run the full length of the Great Wall of China - a feat he already completed in 2006 when he became one of the first people in history to run the 4,200km distance in 93 days. Now, nearly 12 years later, Grier has returned to China to run the wall in the opposite direction. 10 Apr 2018 Read more

Cipla's novel solution to prevent TB in people living with HIV/AIDS
With tuberculosis (TB) estimated to infect around 781 out of every 100,000 South Africans, people living with HIV/AIDS (PLHIV) are currently at the highest risk of both contracting and dying of this condition. 23 Mar 2018 Read more

More patient education needed on respiratory conditions
There is a significant need in South Africa for education around respiratory conditions such as asthma and allergic rhinitis. This according to Dr Shaunagh Emanuel, honorary secretary of the Allergy Society of South Africa (ALLSA) with an Allergy Practice in Cape Town. 21 Feb 2018 Read more

Cannabis legalisation offers medical research opportunities
The impending legalisation of access to medical cannabinoids in South Africa is opening up a host of research opportunities that the medical sector should embrace. This is according to Dr Sean Chetty, Deputy Head of Anesthesiology and Critical Care at the University of Stellenbosch, who adds that a combination of tetrahydrocannabinol (THC) and cannabidiol (CBD), two of the active components in cannabis, may offer new ways to alleviate suffering as a result of certain neurological conditions. 15 Feb 2018 Read more

Ajuga Creche Aid - Equipping unprivileged children for the new school year
We are currently running a campaign for CFSA called Ajuga Creche Aid. The idea is to pack 2,000 shoeboxes of back-to-school goodies or people can donate a shoebox and then have these delivered to the children that attend the Ajuga ECDs and creches. 15 Feb 2018 Read more

Importance of managing cow's milk allergies in infants
The management of cow's milk allergy in infants needs to be a long-term strategy given the risk of poor nutrition and reduced quality of life. 26 Jan 2018 Read more

The correct nasal spray your secret to fight allergies
Over-the-counter nasal sprays can be effective in the treatment of allergies, and understanding their benefits and correct usage can help people to alleviate their nasal symptoms. 25 Jan 2018 Read more

Turning dreams into a reality
We are pleased to announce that our Miles for Smiles partnership with STBB has raised R450,000 for Operation Smile South Africa - a total of 81 children's lives that will now be changed forever! 1 Dec 2017 Read more

What is the Miles for Smiles #GL35Challenge?
On World Smile Day, 6 October 2017, David Grier, Andy Stuart, Jean Lierop and mascot Charlie the dog took up the Miles for Smiles GL35Challenge. 30 Nov 2017 Read more

Is your probiotic gluten-free?
As more information about the benefits of probiotic use is becoming increasingly available, Professor Leon Dicks, head of the probiotic and antimicrobial peptide laboratory in the Department of Microbiology at Stellenbosch University, stresses the importance of choosing a probiotic that is gluten-free. 16 Oct 2017 Read more

Team up against breast cancer
Amongst cancers affecting females, breast cancer still reduces life expectancy when diagnosed. However, if diagnosed early, it is treatable and survival rates are very good. 13 Oct 2017 Read more

Inflammatory bowel disease should not be a career-ender
Inflammatory bowel disease (IBD) affects individuals in their most productive years, but its symptoms should not deter individuals from continuing to practise their chosen professions. This according to Sister Karin Davidson, IBD Nurse at the Vincent Pallotti Hospital, speaking at the recent Congress of the South African Gastroenterology Society and Association of Surgeons of South Africa. 28 Sep 2017 Read more

Positive news for MS sufferers with hopes of becoming parents
Multiple sclerosis (MS) sufferers should not be discouraged from having families, as the view on the prospect of women with MS, carrying pregnancies to term, is shifting. 18 Sep 2017 Read more

More than half (54%) of health-conscious South Africans experience digestive health problems, according to the 2017 Cipla Digestive Health Survey conducted among 400 health-conscious individuals. Respondents indicated that 77% suffer from bloating, 76% said they have constipation and 28% experience regular diarrhoea. 15 Sep 2017 Read more

Celebrating a great man's legacy
On 18 July 2017 South Africans from all walks of life celebrated Mandela Day. 25 Jul 2017 Read more

Cipla collaborates with American Cancer Society to increase access to cancer treatment in Africa
Cipla Ltd, the global pharmaceutical company and owner of Cipla Medpro, South Africa's third-largest pharmaceutical manufacturer, announced a groundbreaking market access agreement with the American Cancer Society (ACS), the Clinton Health Access Imitative (CHAI) and the pharmaceutical company, Pfizer, to expand access to 16 essential cancer treatment medications, including chemotherapies, into Ethiopia, Nigeria, Kenya, Uganda, Rwanda and Tanzania. 7 Jul 2017 Read more

The link between gut bacteria and children developing allergies
The probability that a child will develop an allergy is being proven to be largely related to their microbiome - the bugs that live on us and in us. Research from the University of California, San Francisco shows that if an infant's beneficial microbes, more commonly understood as ‘gut flora', are disturbed in the first few weeks of their life, they have a higher chance of developing allergies and asthma. 2 May 2017 Read more

How probiotics can alleviate the symptoms of IBS
International Irritable Bowel Syndrome Awareness Month 3 Apr 2017 Read more

Medical disaster relief unit assists Hout Bay fire victims
With a recent fire destroying 2,200 homes and leaving about 10,000 people displaced in Mandela Park Hout Bay, the community was left traumatised and in desperate need of support. The Cipla Foundation installed a disaster relief medical unit, which is now fully operational and located on the Hout Bay sports grounds in close proximity to the affected area to provide assistance to the community. 24 Mar 2017 Read more

Medical disaster relief unit deployed to Hout Bay to assist fire victims
An estimated 15,000 people were left homeless after the fire that ravaged Mandela Park Hout Bay left the community traumatised and in desperate need of support. The Cipla Foundation will be deploying a disaster relief medical unit to provide assistance to the affected community. 20 Mar 2017 Read more

#ImpactMoments: Shap'Left Medstores - Eastern Cape
Very often within the NGO space the good work that many NGOs do isn't communicated very well and the story of the people on the ground that have been impacted, how the individuals lives have changed for the better and then as a direct result how their community has benefitted. 15 Mar 2017 Read more

The 4th to the 8th of March 2017 is School Health Week, which presents an excellent reminder for parents about the importance of deworming their children. According to the World Health Organisation, more than 600 million school-age children worldwide are at risk of parasitic worm infections and an estimated 400 million of these children remain untreated. 1 Mar 2017 Read more

Cipla bursary scheme now open for entries
Cipla SA, South Africa's third largest pharmaceutical company, is encouraging all students in their first, second or third/final year, who want to make a difference in the world by becoming a part of the pharmaceutical industry, to apply for a bursary at the company. 14 Feb 2017 Read more

Cipla launches revolutionary respiratory inhaler in SA
Cipla today announced the launch of its innovative inhaler called Synchrobreathe. This state-of-the-art breath-actuated inhaler (BAI) will bring great relief to millions of South Africans with obstructive airway diseases (OAD) such as asthma. 18 Jan 2017 Read more

David Grier to run 1,100km in 20 days to bring 10 smiles to 10 children - The Power of 10 challenge
Cipla Foundation, Cipla SA's social enterprise division, is planning an adventure which will see endurance athletes David Grier and Andrew Stuart running 1,100 kilometres over a period of 20 days with the aim of raising R110,000 over this period for the Cipla Miles for Smiles initiative, which raises funds and awareness for Operation Smile. 14 Nov 2016 Read more

#NotAskingForAnything | Cipla Foundation SA
Our #NotAskingForAnything campaign is more than just a social media hashtag. It's a heartfelt invitation for anyone - from regular, good-hearted people, all the way to big businesses and corporations - to join us in doing whatever we can for real people in need. 7 Nov 2016 Read more

The Evolution of Asthma Treatment
Asthma continues to be a significant problem globally, as the Global Asthma Report lists the disease as the 14th most important disorder in the world in terms of the extent and duration of disability. While current treatment programmes are effective for patients with mild-to-moderate asthma, patients who fail to control their disease can escalate to acute asthma or even become unresponsive to current treatment efforts, placing them at an increased risk of passing away from the disease. 30 Sep 2016 Read more

The global and South African need for ECD centres
A proper foundation is the key to emotional, physical and cognitive success in childhood, as well as later on in life. Investing in Early Childhood Development (ECD) will set children up for these sorts of achievements. The question is, to what extent has the world and, more specifically, South Africa invested in ECD? 13 Sep 2016 Read more

Early childhood development campus launched in Kaboweni- Mbombela
The Department of Social Development in Mbombela, in collaboration with the Cipla Foundation, on 2 June launched a specialised early childhood development (ECD) campus in the informal settlement of Kaboweni. This fire resistant structure is geared to provide quality ECD facilities and services to the 40,000 inhabitants of the settlement. 12 Sep 2016 Read more

Cipla Announces Africa Expansion Strategy During International AIDS Conference
On the 18th July 2016, Cipla Limited today announced that negotiations to establish manufacturing facilities in Morocco and later in Algeria are in advanced stages of discussion. The pharmaceutical aims to establish these facilities through joint ventures, thereby increasing its antiretroviral (ARV) manufacturing capacity in Africa. 18 Jul 2016 Read more

Cipla completes acquisition of generic businesses in US
Cipla, a global pharmaceutical company which uses technology and innovation to meet the everyday needs of all patients, today announced that its UK arm, Cipla (EU) Limited has closed the transaction to acquire two US-based companies, InvaGen Pharmaceuticals Inc., and Exelan Pharmaceuticals Inc. The acquisition was made by Cipla (EU) Limited through a wholly owned special purpose vehicle which would merge into InvaGen Pharmaceuticals Inc. after the acquisition. The combined revenue for the two companies for the year-ended 2015 is over USD230 million. 4 May 2016 Read more

Dr Hamied on Asthma
Patent monopolies on life-saving drugs: the biggest killer of our time? It's a burning issue: should pharmaceutical companies be granted patent monopolies on life-saving drugs they have developed if it is costing millions of lives? 13 Feb 2016 Read more